活在當下🌸天人之間

《 禮記·大學 》 :創造財富的原則,就是生產財富的人多,耗用財富的人少;管理財富的人勤快,使用財富的人適度;這樣,財富就會長久地保持豐足了。

如今聯邦各級政府提供諸多利民舉措,都與創造財富的原則背道而馳。

欠債豈是家財?債台高築,不過飲鴆止渴,終歸禍延子孫。

竹石(清‧鄭燮)咬定青山不放鬆,立根原在破岩中;千磨萬擊還堅勁,任爾東西南北風。

自由黨聯邦少數政府與安省進步保守黨分別在上月7日及28公布了財政預算案,大慷納稅人之慨,以保政黨和個人私利。土豆‧Trudeau痴戀保住權位至2025年,福特就著眼下月2日省選,但是各自採取了不同的策略。

土豆與聯邦新民主黨鉏勉誠結盟,赤裸裸地強行佔領國會,輕易通過民主代議制度,為所欲為。預算開出許多不會或者不能兌現的支票,但是對外宣傳的卻是不單為家國公民謀福祉,還減少溫室氣體排放,守護地球母親。福特跟土豆大不相同,還懂得為民制產,與民分利。安省進步保守黨政綱,比如基礎建設、改善民生、量入為出等等項目,以至於應對武肺大流行,都可以為她的預算案作背書。

我們自負為萬物之靈,祇是因為上天賦予靈性。人類創造語言文字、聚族而居,組織社會,累積文化,創新科技,促進文明。《孟子.離婁下》:人與禽獸的分別處,在於人性有仁義的本質,即是有價值的自覺,有知行善的能力,而飛禽走獸都沒有。

用聖經的說法,人比其他「非人類動物」多了一點東西,就是「按著神的形像被造」,「有靈魂」。人有靈魂於是成為動物的管家,我們不能把動物當作人。神創造每類活物都是各從其類的。靈欲之差,在於義利之別。腦子裡塞满名利私慾而蒙蔽了心智的非人,又怎樣行公義,好憐憫呢?

政黨、政客與及等而下之的政棍,為取得權位為作出的種種治國安民的承諾,都是鏡花水,過眼雲煙。提出的政綱和利民政策、措施,就是兌現執行,耗用的還不是公民辛勤勞動上繳的稅金!政府的收入來源,祇是巧立五花八門的稅收名目,然後向治下民眾徵集。中國大陸民眾稱之為「割韭菜」,取之不盡,用之無竭。

《 禮記·大學 》 :創造財富的原則,就是生產財富的人多,耗用財富的人少;管理財富的人勤快,使用財富的人適度;這樣,財富就會長久地保持豐足了。如今聯邦各級政府提供諸多利民舉措,都與創造財富的原則背道而馳。欠債豈是家財?債台高築,不過飲鴆止渴,終歸禍延子孫。

誰會貪圖一己私利,投下神聖選票?

活在當下🌐厚德載物

🐉三不朽🌸

🌐首富愛龍馬克斯🌀Elon Musk

🤔成就了甚麼⁉

🌀光復🍁榮歸🌸

🥔Malfeasance and abuse of Power🐥瀆職濫權

Malfeasance & abuse of power
🥔
瀆職濫權

Canadian Civil Liberties Association🍁We welcome the government’s decision to revoke the proclamation of emergency – it is overdue. From the outset, however, we have stated that the government did not meet the legal thresholds set out in the Emergencies Act.

We continue to believe that there was an insufficient legal basis for resort to the Emergencies Act and that the orders the government passed under this legislation were unconstitutional.

We also continue to believe that it’s important for the courts to comment on the legal threshold and constitutional issues so as to guide the actions of future governments.

Even though the orders are no longer in force, Canadians are left with the precedent.

加拿大公民自由協會🍁我們歡迎政府決定撤銷緊急狀態公告 – 早就應該這樣做了。然而,從一開始,我們就指出政府沒有達到《緊急情況法》規定的法律門檻。

我們仍然認為,訴諸《緊急情況法》的法律依據不足,政府根據這項立法通過的命令是違憲的。

我們還繼續認為,法院必須就法律門檻和憲法問題發表評論,以指導未來政府的行動。

儘管這些命令不再有效,但加拿大人留下了先例。

似是🌸而非‧Yes🍁No

2019 vs 2021: Election Results So Similar, Yet Country So Different

2019 vs 2021: 推選結果如此相似, 惟國家卻如此不同

Change🍁變天

☠No vax pass☠

No vax pass🍁Down with
the certificates issuers

No vax pass🍁Down with the certificates issuers

‘Several hundred people rallied in downtown Toronto on Saturday to voice their opposition to the vaccine mandates rolled out in Ontario this week.

The crowd set off from Queen’s Park and marched through downtown to protest the new proof-of-vaccination certificates announced by Ontario Premier Doug Ford on Sept. 1. People will need to provide proof of vaccination along with photo ID to access non-essential services such as restaurants, bars, gyms, and other indoor facilities starting Sept. 22.

Some protesters carried signs that read “Preserve and protect our Canadian constitutional rights and freedoms” and “Reject the tyranny of mandatory vaccines” while many chanted “No vax pass.”’

TEAM TRUDEAU LIED👃 PEOPLE DIED

Trudeau 🥔土豆is a lair that had no experience in anything prior to being elected for his socks and hair, and isn’t even capable of learning from anything he’s done in the past 6 years! 

⚖HIS GREATEST ACHIEVENMENT IS PUTTING US IN DEBT.

DID JUSTIN ACHIEVE ANYTHING OTHER THAN A GIANT SPLENDER❓

TEAMMING TRUDEAU IS GOING TO KILL🍁

Team Trudeau is killing Canada
Day Dreaming🍁Election2021

WHO IS GOING TO WORK WHILE GETTING PAY BY THE TAXES PAYERS😷

Cost of living and affordability top election issues: Maru poll (yahoo.com)

Fact check on liar

Day Dreaming🍁Election2021

Day Dreaming🍁Election2021

Trudeau is a lair👃had no experience in anything prior to being elected for his socks and hair, and isn’t even capable of learning from anything he’s done in the past 6 years! 

HIS GREATEST ACHIEVENMENT IS PUTTING US IN DEBT.

🥔

https://www.theepochtimes.com/election-call-comes-before-fallout-from-record-deficits-and-debt-hits-analysts_3951052.html?utm_source=share-btn-copylink

THIRD CCP VIRUS ☠VICCINE DOSE🤔

New data suggests that fully vaccinated individuals are not just contracting COVID,

but could be carrying higher levels of the virus than previously understood and facilitating the spread…

Third vaccine dose?

Efficacy of Pfizer’s (NYSE:PFE) coronavirus vaccine, which is pegged at 96%, declines an average of 6% every two months, according to the company, and effectiveness in groups like the elderly and immunocompromised diminishes even more quickly. As a result, the drugmaker is recommending a third dose of its vaccine that can “strongly” boost protection against the Delta variant. Preliminary data (that has yet to be peer-reviewed or published) even suggests that levels of antibodies from a third booster increases antibody levels five to 10 times higher over its two-dose shots.

Bigger picture: Other frontrunners in the global immunization drive – AstraZeneca (NASDAQ:AZN) and Johnson & Johnson (NYSE:JNJ) – are yet to see the evidence to support the need for booster shots. The two take a similar approach in their COVID-19 vaccine technology, using viral vectors instead of the mRNA jabs produced by Pfizer and Moderna (NASDAQ:MRNA). “There are two dimensions to immunity – antibodies [which] decline over time, but the second, very important dimension of vaccination is the so-called T-cells. They tend to protect people against severe disease, but they also provide durability,” AstraZeneca CEO Pascal Soriot declared. “With the technology we use, we have very high production of T-cells. We’re hoping we can have a durable vaccine that protects for a long period of time.”

While Pfizer intends to seek emergency use authorization for a third dose as soon as next month, the FDA and CDC currently feel that an additional dose is not necessary since Americans “who are fully vaccinated are protected from severe disease and death.” US Surgeon General Dr. Vivek Murthy echoed the view this week, saying, “people do not need to go out and get a booster shot.” Should the dose be approved by the FDA, the vaccine would either need to be amended or, if the vaccine were fully FDA approved, a third dose could be given off label.

Will it be the same formula? The July study conducted by Pfizer involved a third dose of its existing vaccine, but the drugmaker is also exploring whether to add an additional dose it has developed to target the Beta variant. Moderna is meanwhile testing three different booster strategies: a half-dose of the existing vaccine, an additional dose of a new vaccine that targets the Beta variant, and another dose that combines the two. Pfizer is expected to generate $33.5B in COVID-19 vaccine revenue in 2021 and Wall Street analysts have already priced boosters into their financial models for the company and BioNTech (NASDAQ:BNTX), which helped develop the vaccine with Pfizer.

Over in Israel: The country’s health ministry this week recommended booster shots for older adults and to those with weak immune systems, becoming one of the first nations in the world to formally approve a third dose of Pfizer’s vaccine. According to the ministry, a full course of the Pfizer vaccine was just 39% effective at preventing infections caused by the Delta variant, though the vaccine provided high levels of protection against hospitalization (92%) and severe illness (91%). Back in January, Israel struck a vaccines-for-data deal with Pfizer that promised to share vast troves of information from its highly digitized healthcare system in exchange for the continued flow of COVID-19 shots. (15 comments)

Third vaccine dose?

Efficacy of Pfizer’s (NYSE:PFE) coronavirus vaccine, which is pegged at 96%, declines an average of 6% every two months, according to the company, and effectiveness in groups like the elderly and immunocompromised diminishes even more quickly. As a result, the drugmaker is recommending a third dose of its vaccine that can “strongly” boost protection against the Delta variant. Preliminary data (that has yet to be peer-reviewed or published) even suggests that levels of antibodies from a third booster increases antibody levels five to 10 times higher over its two-dose shots.

Bigger picture: Other frontrunners in the global immunization drive – AstraZeneca (NASDAQ:AZN) and Johnson & Johnson (NYSE:JNJ) – are yet to see the evidence to support the need for booster shots. The two take a similar approach in their COVID-19 vaccine technology, using viral vectors instead of the mRNA jabs produced by Pfizer and Moderna (NASDAQ:MRNA). “There are two dimensions to immunity – antibodies [which] decline over time, but the second, very important dimension of vaccination is the so-called T-cells. They tend to protect people against severe disease, but they also provide durability,” AstraZeneca CEO Pascal Soriot declared. “With the technology we use, we have very high production of T-cells. We’re hoping we can have a durable vaccine that protects for a long period of time.”

While Pfizer intends to seek emergency use authorization for a third dose as soon as next month, the FDA and CDC currently feel that an additional dose is not necessary since Americans “who are fully vaccinated are protected from severe disease and death.” US Surgeon General Dr. Vivek Murthy echoed the view this week, saying, “people do not need to go out and get a booster shot.” Should the dose be approved by the FDA, the vaccine would either need to be amended or, if the vaccine were fully FDA approved, a third dose could be given off label.

Will it be the same formula? The July study conducted by Pfizer involved a third dose of its existing vaccine, but the drugmaker is also exploring whether to add an additional dose it has developed to target the Beta variant. Moderna is meanwhile testing three different booster strategies: a half-dose of the existing vaccine, an additional dose of a new vaccine that targets the Beta variant, and another dose that combines the two. Pfizer is expected to generate $33.5B in COVID-19 vaccine revenue in 2021 and Wall Street analysts have already priced boosters into their financial models for the company and BioNTech (NASDAQ:BNTX), which helped develop the vaccine with Pfizer.

Over in Israel: The country’s health ministry this week recommended booster shots for older adults and to those with weak immune systems, becoming one of the first nations in the world to formally approve a third dose of Pfizer’s vaccine. According to the ministry, a full course of the Pfizer vaccine was just 39% effective at preventing infections caused by the Delta variant, though the vaccine provided high levels of protection against hospitalization (92%) and severe illness (91%). Back in January, Israel struck a vaccines-for-data deal with Pfizer that promised to share vast troves of information from its highly digitized healthcare system in exchange for the continued flow of COVID-19 shots. (15 comments)

Wall Street Breakfast: Debt Drama | Seeking Alpha

Comments

Don Bruno,

The headlines just keep pouring in…

159 Dead, 593 Hospitalized in Illinois Breakthrough COVID Cases

27 fully vaccinated people have died in Tennessee,

health department says 

More Than 5,100 Breakthrough COVID Cases Reported in Mass.;

at Least 80 Have Died

Report: Vaccinated Comprise 75% of Coronavirus Infections in Singapore

Over One Quarter of Coronavirus Cases in LA County Are Among Fully Vaccinated

Yes, covid vaccines are spreading variants

New data suggests that fully vaccinated individuals are not just contracting COVID, but could be carrying higher levels of the virus than previously understood and facilitating the spread, my NBC news colleagues are reporting.

Vaccinated people quickly went from being the “solution” to now part of the “problem”


Do these vaccines work?

Death rate from variant COVID virus six times higher for vaccinated than unvaccinated, UK health data show…

%d 位部落客按了讚: